Impact News +++ Vistra Launches Senior Notes Offering Due 2031 And 2036 (AFX) +++ VISTRA Aktie +3,66%

SOPHIA GENETICS Aktie

>SOPHIA GENETICS Aktienkurs

4.96 EUR +8.3% (Tradegate)

Ask: 4.36 EUR / 1830 Stück

Bid: 4.28 EUR / 1880 Stück

Tagesumsatz: 100 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

Aktie über LYNX handeln

Intraday

1 Jahr

>SOPHIA GENETICS Performance

1 Woche: +17,1%

1 Monat: +15,9%

3 Monate: +15,3%

6 Monate: +46,2%

1 Jahr: +60,5%

laufendes Jahr: +15,9%

>SOPHIA GENETICS Aktie

Name:

SOPHIA GENETICS SF -,05

Land:

Schweiz

Sektor:

Gesundheit

ISIN/ Wkn:

CH1125843347 / A3CVT8

Symbol/ Ticker:

90B (Frankfurt) / SOPH (NASDAQ)

Kürzel:

FRA:90B, ETR:90B, 90B:GR, NASDAQ:SOPH

Index:

Webseite:

https://www.sophiagenetic..

Profil:

Sophia Genetics SA is a global leader in data-driv..
>Volltext..

Marktkapitalisierung:

289.25 Mio. EUR

Unternehmenswert:

273.68 Mio. EUR

Umsatz:

63 Mio. EUR

EBITDA:

-51.62 Mio. EUR

Nettogewinn:

-64.45 Mio. EUR

Gewinn je Aktie:

-0.96 EUR

Schulden:

54.47 Mio. EUR

Liquide Mittel:

70.15 Mio. EUR

Operativer Cashflow:

-35.08 Mio. EUR

Bargeldquote:

2.21

Umsatzwachstum:

7.85%

Gewinnwachstum:

0.36%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

SOPHIA GENETICS, SOPHIA GENETIC

Letzte Datenerhebung:

12.01.26

>Kennzahlen

Aktien/ Unternehmen:

Aktien: 67.85 Mio. St.

Frei handelbar: 78.22%

Leerverk. Aktien: 0.05%

Rückkaufquote: -0.07%

Mitarbeiter: 423

Umsatz/Mitarb.: 0.13 Mio. EUR

Analysten:

Analystenrating: Strong buy

Kursziel: 40.9%

Bewertung:

KGV: -

KGV lG: -

KUV: 4.7

KBV: 5.9

PEG-Ratio: -1.72

EV/EBITDA: -

Rentabilität:

Bruttomarge: 67.52%

Gewinnmarge: -102.29%

Operative Marge: -94.73%

Managementeffizenz:

Gesamtkaprendite: -43.97%

Eigenkaprendite: -86.09%

>Peer Group

Es sind 39 Aktien bekannt.

>SOPHIA GENETICS Chart & Kurs - NASDAQ

>SOPHIA GENETICS News

12.01.26 - 13:09	SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan (PR Newswire)
	The Company finishes 2025 with strong Q4 performance, expects 20-22% revenue growth in 2026, and promotes Ross Muken to CEO BOSTON and ROLLE, Switzerland, Jan. 12, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today provided......

12.01.26 - 13:09	Corporate News: SOPHiA GENETICS (EQS)
	SOPHiA GENETICS gibt vorläufige Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2025 bekannt, veröffentlicht Prognose für 2026 und kündigt Plan für Wechsel in der Geschäftsführung an...

07.01.26 - 17:30	Sophia Genetics: Aktie legt nach Partnerschaft mit MD Anderson Krebszentrum zu (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

07.01.26 - 14:06	SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology (PR Newswire)
	BOSTON and HOUSTON, Jan. 7, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and The University of Texas MD Anderson Cancer Center today announced a strategic collaboration that unites SOPHiA GENETICS' AI-powered analytics with MD......

11.11.25 - 16:51	SOPHiA Genetics inks two deals to advance AI for precision medicine (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

11.11.25 - 14:03	SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine (PR Newswire)
	BOSTON and SAN DIEGO, Nov. 11, 2025 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pace and accessibility of scientific discovery, today announced at the Association for......

04.11.25 - 13:57	SOPHiA Genetics GAAP EPS of -$0.30 misses by $0.06, revenue of $19.5M beats by $1.37M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

04.11.25 - 12:48	SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance (PR Newswire)
	BOSTON and ROLLE, Switzerland, Nov. 4, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today reported financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Results Revenue was $19.5 million, up......

21.10.25 - 14:01	SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025 (PR Newswire)
	BOSTON and ROLLE, Switzerland, Oct. 21, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today announced it will release its financial results for the third quarter 2025 before U.S. markets open on Tuesday, November 4, 2025. On that......

17.10.25 - 17:48	Corporate News: SOPHiA GENETICS (EQS)
	A.D.A.M. Innovations und SOPHiA GENETICS kooperieren, um Flüssigbiopsie-Tests und Begleitdiagnostik für Präzisionsonkologie in Japan voranzutreiben...

16.10.25 - 17:09	Corporate News: SOPHiA GENETICS (EQS)
	A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan...

16.10.25 - 17:06	A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan (PR Newswire)
	ROLLE, Switzerland and TOKYO, Oct. 16, 2025 /PRNewswire/ -- A.D.A.M. Innovations, Japan's leading private genetic testing company, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company pioneering data-driven medicine, today announced at ESMO a strategic agreement to bring......

16.10.25 - 10:03	SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology (PR Newswire)
	BOSTON and ROLLE, Switzerland, Oct. 16, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in AI-driven precision medicine, today announced the launch of SOPHiA DDM™ Digital Twins, a breakthrough research technology that creates dynamic, virtual representations of individual......

14.10.25 - 05:45	Biotech Stocks Surge After Hours On Trial Updates, Data Momentum (RTTNews)
	Biotech names led the after-hours rally, with SOPHiA GENETICS (SOPH) jumping nearly 10% and SELLAS Life Sciences (SLS) gaining 3.5% after announcing upcoming ESMO 2025 data on its CDK9 inhibitor....

23.09.25 - 14:03	Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy (PR Newswire)
	SALT LAKE CITY and BOSTON, Sept. 23, 2025 /PRNewswire/ -- Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, announced a strategic collaboration to......

23.09.25 - 14:03

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy (GlobeNewswire EN)

SALT LAKE CITY and BOSTON, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, announced a strategic collaboration to develop and provide pharmaceutical companies with an innovative global liquid biopsy companion diagnostic (CDx) test. This partnership will leverage Myriad's advanced laboratory capabilities in the U.S. to support global testing for clinical trials and SOPHiA GENETICS' broad, decentralized network of more than 800 connected institutions in more than 70 countries for global test deployment....

22.09.25 - 14:48	SOPHiA GENETICS Expands Partnership With AstraZeneca To Advance AI-Powered Cancer Diagnostics (AFX)
	LONDON (dpa-AFX) - SOPHiA GENETICS SA (SOPH), a health technology firm focused on data-driven precision medicine, announced on Monday an expansion of its partnership with AstraZeneca PLC (AZN).Thr......

22.09.25 - 14:03	SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer (PR Newswire)
	BOSTON, Sept. 22, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, today announced an expansion of its collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) from the World CB & CDx Summit in Boston. The companies aim to improve......

08.09.25 - 17:15	SOPHiA GENETICS und Jessa Ziekenhuis verkünden Partnerschaft im Bereich der Präzisionsonkologie auf dem Europäischen Kongress für Pathologie (News Aktuell)
	Sophia Genetics: Boston und Rolle, Schweiz (ots/PRNewswire) - SOPHiA GENETICS (Nasdaq: SOPH), ein Cloud-natives Technologieunternehmen im Gesundheitswesen und weltweit führend im Bereich der datengesteuerten Medizin, hat eine bedeutende neue Zusammenarbeit mit dem ......

05.09.25 - 10:09	SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology (PR Newswire)
	BOSTON and ROLLE, Switzerland, Sept. 5, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, has announced a significant new collaboration with Jessa Ziekenhuis in Hasselt, Belgium. The institutions......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Von dem Augenblicke an, wo er das Licht der Welt erblickt, sucht ein Mensch aus ihrem Wirrwarr, in welchem auch er mit allem andern bunt durcheinander herumgewürfelt wird, sich herauszufinden und sich zu gewinnen. - Max Stirner

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram